Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.700
-0.040 (-2.30%)
Apr 21, 2026, 1:53 PM EDT - Market open

PACB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5135655392,6271,8534,521
Market Cap Growth
44.86%4.80%-79.49%41.76%-59.02%-9.36%
Enterprise Value
934.8987.13811.262,9192,0184,423
Last Close Price
1.701.871.839.818.1820.46
PE Ratio
--1.03-1.15-8.11-5.84-22.99
PS Ratio
3.203.533.5013.1014.4434.64
PB Ratio
98.23105.561.063.753.295.72
P/TBV Ratio
95.33104.871.043.553.265.28
P/FCF Ratio
--4.96-2.54-9.80-6.62-38.61
P/OCF Ratio
--5.08-2.61-10.13-7.04-40.67
EV/Sales Ratio
5.846.175.2714.5615.7333.89
EV/EBITDA Ratio
--5.76-1.87-9.27-6.80-21.80
EV/EBIT Ratio
--1.78-1.71-8.73-6.57-21.02
EV/FCF Ratio
--8.66-3.82-10.89-7.21-37.77
Debt / Equity Ratio
131.24131.241.311.321.671.20
Debt / EBITDA Ratio
-4.10-4.10-1.55-2.97-3.19-4.70
Debt / FCF Ratio
-6.17-6.17-3.17-3.48-3.38-8.14
Net Debt / Equity Ratio
79.0679.060.560.430.31-0.11
Net Debt / EBITDA Ratio
-2.47-2.47-0.65-0.96-0.590.45
Net Debt / FCF Ratio
-3.71-3.71-1.33-1.13-0.620.77
Asset Turnover
0.160.160.100.110.070.11
Inventory Turnover
2.022.021.862.722.093.67
Quick Ratio
4.324.326.307.033.0014.90
Current Ratio
5.155.157.487.813.2415.36
Return on Equity (ROE)
-213.45%-213.45%-51.30%-48.53%-46.42%-32.18%
Return on Assets (ROA)
-54.21%-54.21%-31.59%-18.36%-16.28%-11.46%
Return on Invested Capital (ROIC)
-86.49%-86.49%-50.37%-32.18%-32.94%-28.04%
Return on Capital Employed (ROCE)
-58.14%-58.14%-33.34%-21.20%-17.87%-18.21%
Earnings Yield
-106.74%-97.33%-86.89%-12.33%-17.11%-4.35%
FCF Yield
-22.26%-20.18%-39.39%-10.20%-15.11%-2.59%
Buyback Yield / Dilution
-9.28%-4.02%-13.70%-12.95%-10.00%-16.67%
Total Shareholder Return
-9.28%-4.02%-13.70%-12.95%-10.00%-16.67%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q